BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 27938789)

  • 21. The role of endoscopy in inflammatory bowel disease.
    Bharadwaj S; Tandon P; Kulkarni G; Rivas J; Charles R
    J Dig Dis; 2015 Dec; 16(12):689-98. PubMed ID: 26595156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?
    Moussata D; Allez M; Cazals-Hatem D; Treton X; Laharie D; Reimund JM; Bertheau P; Bourreille A; Lavergne-Slove A; Brixi H; Branche J; Gornet JM; Stefanescu C; Moreau J; Marteau P; Pelletier AL; Carbonnel F; Seksik P; Simon M; Fléjou JF; Colombel JF; Charlois AL; Roblin X; Nancey S; Bouhnik Y; Berger F; Flourié B;
    Gut; 2018 Apr; 67(4):616-624. PubMed ID: 28115492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surveillance in inflammatory bowel disease: chromoendoscopy and digital mucosal enhancement.
    Naymagon S; Marion JF
    Gastrointest Endosc Clin N Am; 2013 Jul; 23(3):679-94. PubMed ID: 23735110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colorectal Neoplasia in the Setting of Inflammatory Bowel Disease.
    Walsh M; Rahman S; Gologorsky R; Tsikitis VL
    Surg Clin North Am; 2024 Jun; 104(3):673-684. PubMed ID: 38677829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colorectal dysplasia in inflammatory bowel disease: a clinicopathologic perspective.
    Rutter MD; Riddell RH
    Clin Gastroenterol Hepatol; 2014 Mar; 12(3):359-67. PubMed ID: 23756224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colorectal cancer screening and surveillance in patients with inflammatory bowel disease in 2021.
    Huguet JM; Ferrer-Barceló L; Suárez P; Sanchez E; Prieto JD; Garcia V; Sempere J
    World J Gastroenterol; 2022 Feb; 28(5):502-516. PubMed ID: 35316962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Practice pattern variability among gastroenterologists in colorectal cancer surveillance and management of colorectal dysplasia in inflammatory bowel disease.
    Chan WPW; Tan YB; Shim HH; Kaltenbach T; Soetikno R
    J Dig Dis; 2021 Aug; 22(8):463-472. PubMed ID: 34173325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of nonpolypoid colorectal neoplasia using magnifying endoscopy in colonic inflammatory bowel disease.
    Oka S; Tanaka S; Chayama K
    Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):405-17. PubMed ID: 24975531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysplasia and cancer in inflammatory bowel disease.
    Basseri RJ; Basseri B; Papadakis KA
    Expert Rev Gastroenterol Hepatol; 2011 Feb; 5(1):59-66. PubMed ID: 21309672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory bowel disease cancer surveillance in a tertiary referral hospital: attitudes and practice.
    Verschuren EC; Ong DE; Kamm MA; Desmond PV; Lust M
    Intern Med J; 2014 Jan; 44(1):40-9. PubMed ID: 24015799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colorectal cancer in inflammatory bowel disease: review of the evidence.
    Keller DS; Windsor A; Cohen R; Chand M
    Tech Coloproctol; 2019 Jan; 23(1):3-13. PubMed ID: 30701345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endoscopic detection and resection of dysplasia in inflammatory bowel disease-techniques with videos.
    Khalid S; Abbass A; Khetpal N; Shen B; Navaneethan U
    Int J Colorectal Dis; 2019 Apr; 34(4):569-580. PubMed ID: 30854573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease.
    Laine L; Kaltenbach T; Barkun A; McQuaid KR; Subramanian V; Soetikno R;
    Gastrointest Endosc; 2015 Mar; 81(3):489-501.e26. PubMed ID: 25708752
    [No Abstract]   [Full Text] [Related]  

  • 34. Surveillance strategies in inflammatory bowel disease.
    Schmidt C; Bielecki C; Felber J; Stallmach A
    Minerva Gastroenterol Dietol; 2010 Jun; 56(2):189-201. PubMed ID: 20485256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality bowel preparation for surveillance colonoscopy in patients with inflammatory bowel disease is a must.
    Nett A; Velayos F; McQuaid K
    Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):379-92. PubMed ID: 24975529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An Update on Surveillance in Ulcerative Colitis.
    Limdi JK; Farraye FA
    Curr Gastroenterol Rep; 2018 Mar; 20(2):7. PubMed ID: 29516293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel diagnostic and therapeutic techniques for surveillance of dysplasia in patients with inflammatory bowel disease.
    Iacucci M; Uraoka T; Fort Gasia M; Yahagi N
    Can J Gastroenterol Hepatol; 2014; 28(7):361-70. PubMed ID: 25157526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysplasia and colorectal cancer surveillance in inflammatory bowel disease.
    Pulusu SSR; Lawrance IC
    Expert Rev Gastroenterol Hepatol; 2017 Aug; 11(8):711-722. PubMed ID: 28475382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory bowel disease: the problems of dysplasia and surveillance.
    Mitchell PJ; Salmo E; Haboubi NY
    Tech Coloproctol; 2007 Dec; 11(4):299-309. PubMed ID: 18060357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Full-Spectrum Endoscopy Improves Surveillance for Dysplasia in Patients With Inflammatory Bowel Diseases.
    Leong RW; Ooi M; Corte C; Yau Y; Kermeen M; Katelaris PH; McDonald C; Ngu M
    Gastroenterology; 2017 May; 152(6):1337-1344.e3. PubMed ID: 28126349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.